MoonLake Immunotherapeutics (MLTX)
Data as of , from SEC Form 4 filings.
See up to 3 months of MLTX. The 7-day demo opens the 1M and 3M ranges and puts MLTX on your watchlist.
Start 7-day demoLatest MLTX insider trades
About MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics is an SEC registrant, filing under CIK 0001821586, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
MLTX Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 113,353 | $2.27M |
MLTX insider transactions (Form 4)
5334 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Kristian Reich - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 1,100 | $20.00 | $22K | |
| Kristian Reich - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 50,000 | $20.02 footnote F2 | $1.00M | |
| Kristian Reich - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 2,448 | $20.00 | $49K | |
| ||||||
| Kristian Reich - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 43,700 | $20.09 footnote F2 | $878K | |
| ||||||
| Kristian Reich - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 16,105 | $20.01 footnote F2 | $322K | |
| ||||||
| da Silva Jorge Santos - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 33,936 | $20.01 footnote F2 | $679K | |
| da Silva Jorge Santos - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 68,289 | $20.02 footnote F3 | $1.37M | |
| ||||||
| da Silva Jorge Santos - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 47,775 | $20.03 footnote F2 | $957K | |
| ||||||
| Open-market sale | Class A ordinary shares, par value $0.0001 per share | 39,120 | $22.04 footnote F2 | $862K | ||
| ||||||
| BVF PARTNERS L P - Director | Grant or award | Option to Buy | 22,195 | $0.00 | - | |
| Open-market sale | Class A ordinary shares, par value $0.0001 per share | 15,082 | $19.68 footnote F2 | $297K | ||
| Open-market sale | Class A ordinary shares, par value $0.0001 per share | 2,794 | $19.60 footnote F3 | $55K | ||
| ||||||
| Andrew John Phillips - Director | Grant or award | Option to Buy | 22,195 | $0.00 | - | |
| Spike Loy - Director | Grant or award | Option to Buy | 22,195 | $0.00 | - | |
| Catherine Moukheibir - Director | Grant or award | Option to Buy | 22,195 | $0.00 | - | |
| Grant or award | Option to Buy | 22,195 | $0.00 | - | ||
| Kristian Reich - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 50,000 | $19.43 footnote F5 | $972K | |
| Kristian Reich - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 50,000 | $18.89 footnote F2 | $945K | |
| Kristian Reich - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 50,000 | $18.70 footnote F4 | $935K | |
| ||||||
| Open-market sale | Class A ordinary shares, par value $0.0001 per share | 13,653 | $20.02 footnote F2 | $273K | ||
| ||||||
| Open-market sale | Class A ordinary shares, par value $0.0001 per share | 2,426 | $19.56 footnote F2 | $47K | ||
| ||||||
| da Silva Jorge Santos - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 98,127 | $18.41 footnote F2 | $1.81M | |
| da Silva Jorge Santos - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 51,873 | $18.23 footnote F3 | $946K | |
| ||||||
| Open-market sale | Class A ordinary shares, par value $0.0001 per share | 85,870 | $18.94 footnote F2 | $1.63M | ||
| Open-market sale | Class A ordinary shares, par value $0.0001 per share | 1,925 | $19.51 footnote F3 | $38K | ||
| ||||||
| BVF PARTNERS L P - Director | Open-market sale | Class A Ordinary Shares, $0.0001 par value | 1,932,354 | $16.79 | $32.44M | |
| BVF PARTNERS L P - Director | Open-market sale | Class A Ordinary Shares, $0.0001 par value | 1,569,116 | $16.79 | $26.35M | |
| BVF PARTNERS L P - Director | Open-market sale | Class A Ordinary Shares, $0.0001 par value | 248,530 | $16.79 | $4.17M | |
| Grant or award | Class A ordinary shares, par value $0.0001 per share | 354,296 | $0.00 | - | ||
| da Silva Jorge Santos - Officer | Grant or award | Stock Option (Right to Buy) | 520,342 | $0.00 | - | |
| Kristian Reich - Officer | Grant or award | Stock Option (Right to Buy) | 520,342 | $0.00 | - | |
| Other | Class A ordinary shares, par value $0.0001 per share | 294,473 | - footnote F2 | - | ||
| Derivative | Class C ordinary shares, par value $0.0001 per share | 294,473 | - footnote F2 | - | ||
| Other | Common shares, par value CHF 0.10 per share, of MoonLake AG | 8,754 | - footnote F2 | - | ||
| ||||||
| Kristian Reich - Officer | Other | Class A ordinary shares, par value $0.0001 per share | 35,389 | - footnote F2 | - | |
| Kristian Reich - Officer | Derivative | Class C ordinary shares, par value $0.0001 per share | 35,389 | - footnote F2 | - | |
| Kristian Reich - Officer | Other | Common shares, par value CHF 0.10 per share, of MoonLake AG | 1,052 | - footnote F2 | - | |
| ||||||
| da Silva Jorge Santos - Officer | Other | Class A ordinary shares, par value $0.0001 per share | 196,316 | - footnote F2 | - | |
| da Silva Jorge Santos - Officer | Derivative | Class C ordinary shares, par value $0.0001 per share | 196,316 | - footnote F2 | - | |
| da Silva Jorge Santos - Officer | Other | Common shares, par value CHF 0.10 per share, of MoonLake AG | 5,836 | - footnote F2 | - | |
| ||||||
| da Silva Jorge Santos - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 130,000 | $15.08 footnote F2 | $1.96M | |
| da Silva Jorge Santos - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 70,000 | $14.49 | $1.01M | |
| ||||||
| Kristian Reich - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 130,000 | $15.08 footnote F2 | $1.96M | |
| Kristian Reich - Officer | Open-market sale | Class A ordinary shares, par value $0.0001 per share | 72,908 | $14.43 | $1.05M | |
| ||||||
| Open-market purchase | Class A ordinary shares, par value $0.0001 per share | 10,870 | $9.09 footnote F1 | $99K | ||
| ||||||
| Open-market sale | Class A Ordinary Shares | 70,748 | $9.38 | $664K | ||
| Open-market sale | Class A Ordinary Shares | 232,460 | $8.40 | $1.95M | ||
| Open-market sale | Class A Ordinary Shares | 3,390,943 | $7.58 | $25.70M | ||
| Open-market sale | Class A Ordinary Shares | 2,800,000 | $6.61 | $18.51M | ||
| Open-market sale | Class A Ordinary Shares | 5,827 | $6.96 | $41K | ||
| Kristian Reich - Officer | Other | Class A ordinary shares, par value $0.0001 per share | 48,978 | - | - | |
| Kristian Reich - Officer | Derivative | Class C ordinary shares, par value $0.0001 per share | 48,978 | - | - | |
| Kristian Reich - Officer | Other | Common shares, par value CHF 0.10 per share, of MoonLake AG | 1,456 | - | - | |
Recent MLTX Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| - | - | - | - | View on EDGAR | |
| - | - | - | - |
MLTX insider trading FAQ
What is the latest insider trade for MLTX?
MoonLake Immunotherapeutics (MLTX) had 4 insider filings in the last 90 days, with the most recent on 2026-07-29. The full record for MLTX runs to 34 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying MLTX stock?
No insider purchases of MLTX were filed in the last 90 days. 1 purchase is on record for this company.
How many insiders are selling MLTX stock?
5 insider sales of MLTX were filed in the last 90 days, totaling $2.27M.
Where can I see MLTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects MLTX Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Kristian Reich view on EDGAR
- - Kristian Reich view on EDGAR
- - Kristian Reich view on EDGAR
- - Kristian Reich view on EDGAR
- - da Silva Jorge Santos view on EDGAR
- - da Silva Jorge Santos view on EDGAR
- - Matthias Bodenstedt view on EDGAR
- - BVF PARTNERS L P view on EDGAR
- - Matthias Bodenstedt view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where MLTX's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow MLTX with a 7-day demo
- MLTX on your watchlist
- Every MLTX Form 4 filing on record
- Up to 3 months of MLTX price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive